The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat

Behavioural Brain Research

Volumn 191, Issue 2, 2008, Pages 184-189

  Monti, Jaime M ^a   Leopoldo, Marcello ^b   Jantos, Héctor ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

5 HT7 receptor; Dorsal raphe nucleus; LP 44; REM sleep; SB 269970; Serotonin; Sleep

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 4 AMINOBUTYRIC ACID RECEPTOR; LIGAND; LP 44; SEROTONIN 7 RECEPTOR; LIPOPROTEIN; LIPOPROTEIN LP44; OUTER MEMBRANE PROTEIN; PHENOL DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SULFONAMIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; LIGHT DARK CYCLE; MALE; NONHUMAN; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP PATTERN; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; DOSE RESPONSE; RAPHE NUCLEUS; REACTION TIME; SLEEP STAGE; WAKEFULNESS; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPROTEINS; MALE; PHENOLS; RAPHE NUCLEI; RATS; RATS, WISTAR; REACTION TIME; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SLEEP STAGES; SLEEP, REM; SULFONAMIDES; WAKEFULNESS;

EID: 43849098395     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.03.025     Document Type: Article

References (44)

1. Baghdoyan H.A., and Lydic R. Neurotransmitters and neuromodulators regulating sleep. In: Bazil C.W., Malow B.A., and Sammaritano B.L. (Eds). Sleep and epilepsy: the clinical spectrum (2002), Elsevier, Amsterdam 17-44
2. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152
3. 3H]aspartate labeling of possible excitatory amino acid inputs. Neuroscience 37 (1990) 77-100
4. 7 receptors. J Neurosci 24 (2004) 4807-4817
5. 7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents. J Pharmacol Exp Ther 321 (2007) 690-698
6. 7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J Pharmacol Exp Ther 297 (2001) 395-402
7. Commons K.G., Beck S.G., and Bey V.W. Two populations of glutamatergic axons in the rat dorsal raphe nucleus defined by the vesicular glutamate transporters 1 and 2. Eur J Neurosci 21 (2005) 1577-1586
8. Descarries L., Watkins K.C., García S., and Beaudet A. The serotonin neurons in nucleus raphe dorsalis of adult rat: a light and electron microscope radioautographic study. J Comp Neurol 207 (1982) 239-254
9. 1A receptors in discrete regions of the circadian timing system in hamsters. Brain Res 829 (1999) 39-45
10. 7 receptor immunoreactivity in the rat brain. Soc Neurosci Abstr 380 (2001) 18
11. 7 receptor antagonist, attenuate circadian phase advances induced by microinjections of serotonergic drugs in the hamster dorsal raphe nucleus. Brain Res 1008 (2004) 40-48
12. Ferraro G., Montalbano M.E., Sardo P., and La Grutta V. Lateral habenular influence on dorsal raphe nucleus. Brain Res Bull 41 (1996) 47-52
13. Ford B., Holmes C.J., Mainville L., and Jones B.E. GABAergic neurons in the rat pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J Comp Neurol 363 (1995) 177-196
14. Glass J.D., Grossman G.H., Farnbauch L., and DiNardo L. Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J Neurosci 23 (2003) 7451-7460
15. 7 receptor in rat brain. Br J Pharmacol 117 (1996) 657-666
16. 7 receptor antagonist. Br J Pharmacol 130 (2000) 539-548
17. 3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction. Neurochem Res 29 (2004) 1487-1497
18. 7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol Psychiatry 58 (2005) 31-37
19. 7) receptor isoforms produced by alternative splicing. Neuropharmacology 37 (1998) 1621-1632
20. Jankowski M.P., and Sesack S.R. Prefrontal cortical projections to the rat dorsal raphe nucleus: ultrastructural features and associations with serotonin and gamma-aminobutyric acid neurons. J Comp Neurol 468 (2004) 518-529
21. Jolas T., and Aghajanian G.K. Opioids suppress spontaneous and NMDA-induced inhibitory postsynaptic currents in the dorsal raphe nucleus of the rat in vitro. Brain Res 755 (1997) 229-245
22. Lee H.S., Kim M.A., Valentino R.J., and Waterhouse B.D. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res 963 (2003) 57-71
23. 7 receptor agents. J Med Chem 47 (2004) 6616-6624
24. Li Y.Q., Li H., Kaneko T., and Mizuno N. Morphological features and electrophysiological properties of serotonergic and non-serotonergic projection neurons in the dorsal raphe nucleus. Brain Res 900 (2001) 110-118
25. 7) implicated in the regulation of mammalian circadian rhythms. Neuron 11 (1993) 449-458
26. Molliver M.E. Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7 (1987) 2S-23S
27. Monti J.M., Hawkins M., Jantos H., Labraga P., and Fernández J. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 95 (1988) 395-400
28. 1A receptor ligands flesinoxan and WAY 100635 given systematically or microinjected into the lateral tegmental nucleus on REM sleep in the rat. Behav Brain Res 151 (2004) 159-166
29. 2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat. Eur J Pharmacol 553 (2006) 163-170
30. 7 receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat. Behav Brain Res 167 (2006) 245-250
31. Monti J.M., Jantos H., and Monti D. Serotonin and sleep-wake regulation. In: Monti J.M., Pandi-Perumal S.R., and Sinton C.M. (Eds). Neurochemistry of sleep and wakefulness (2008), Cambridge University Press, Cambridge 242-277
32. 7) receptor immunoreactivity-positive "stigmoid body"-like structure in developing rat brains. Int J Dev Neurosci 21 (2003) 133-143
33. 7(a). J Biol Chem 278 (2003) 3098-3104
34. 5A receptor immunoreactivity in the rat brain. Br Neurosci Assoc Abstr 15 (1999) 79
35. Pace-Schott E.F., and Hobson J.A. Basic mechanisms of sleep: new evidence of the neuroanatomy and neuromodulation of the NREM-REM cycle. In: Davis K.L., Charney D., Coyle J.T., and Nemeroff C. (Eds). Neuropsychopharmacology-the fifth generation of progress (2002), Lippincott Williams & Wilkins, Philadelphia 1859-1877
36. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates-the new coronal set. 5th ed. (2005), Academic Press, Sidney
37. 7 receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol 132 (2001) 1574-1580
38. 7 receptor-mediated effects on 5-HT efflux in the guinea-pig dorsal raphe nucleus. Neuropharmacology 46 (2004) 935-941
39. 7) activating cAMP formation. Proc Natl Acad Sci USA 90 (1993) 8547-8551
40. 7 serotonin receptor subtype. J Biol Chem 268 (1993) 18200-18204
41. 7 receptor antagonist, modulates REM sleep in rats. Br J Pharmacol 139 (2003) 705-714
42. 5A receptor in guinea pig brain. Neuropharmacology 51 (2006) 566-577
43. 7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons. Brain Res 993 (2003) 230-234
44. 7 receptors: current knowledge and future prospects. Trends Pharmacol Sci 21 (2000) 70-77